Clinical Trial Update: A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

A prospective Phase II randomized study evaluating chidamide in combination with camrelizumab and apatinib for advanced esophageal cancer; the trial is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Chidamide (chidamide)

Snippet

Sponsor: Peking University | Conditions: Advanced Esophageal Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING